DMIIU Drugs Made In America Acquisition II Corp.

Nasdaq Blank Checks CIK: 0002040475
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

DMIIU is a blank-check company with severely deteriorated financial fundamentals, negative stockholders' equity of -$17.3M, and persistent operating losses. The company is burning cash at an unsustainable rate (-$703.4K operating cash flow) with minimal liquid assets ($315.1K) relative to liabilities, indicating an imminent liquidity crisis.

Strengths

  • + Current ratio of 1.32x suggests near-term liquidity coverage
  • + Total assets of $501.0M provide a buffer, though largely composed of intangible assets typical of SPACs
  • + Negative insider activity suggests limited principal exposure at risk

Risks

  • ! Negative stockholders' equity of -$17.3M indicates technical insolvency and shareholder dilution risk
  • ! Operating cash burn of -$703.4K with only $315.1K cash on hand creates critical liquidity runway of less than 6 weeks
  • ! No revenue generation, negative operating income (-$252.9K), and negative net income (-$143.6K) demonstrate fundamental business model failure
  • ! Blank-check company structure with no evidence of successful acquisition or business combination
  • ! Zero insider Form 4 filings suggest management disengagement and lack of confidence

Key Metrics to Watch

Financial Metrics

Revenue
N/A
Net Income
-143.6K
EPS (Diluted)
$0.00
Free Cash Flow
-703.4K
Total Assets
501.0M
Cash
315.1K

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA 0.0%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
1.32x
Quick Ratio
1.32x
Debt/Equity
N/A
Debt/Assets
3.6%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-23T15:36:12.147855 | Data as of: 2025-09-30 | Powered by Claude AI